RankAlpha logo
Back to Rankings

BBOT

BridgeBio Oncology TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BBOT vs peer average
15/100
BBOT vs. peer average (F vs. B)
Grade spread
A 2 · B 2 · C 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ZVRA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $679.23M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerZVRAZevra Therapeutics
BBOT
BridgeBio Oncology Therapeutics
ZVRA
Zevra Therapeutics
Grade
F
A
Momentum
17
75
Value
51
41
Sentiment
-
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ZVRA

BBOT / ZVRA
Grade Position
Below peers
BBOT vs. peer average (F vs. B)
15/100
Momentum
17
ZVRA
Value
51
BBOT
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BBOT
1
ZVRA
Zevra Therapeutics Inc Common
A
100/100
-4
2
CLYM
Climb Bio Inc Common
B
80/100
-3
3
ANRO
Alto Neuroscience Inc Common
B
80/100
-3
4
CRMD
CorMedix Inc Common
A
100/100
-4
5
SLDB
Solid Biosciences Inc Common
C
60/100
-2
ZVRA is the first peer returned for this comparison set.